FDA warns about azithromycin in some cancers
Aug 07, 2018•8 min•Season 1Ep. 131
Episode description
The FDA has issued a safety alert warning against long-term use of azithromycin to prevent bronchiolitis obliterans syndrome in patients with blood or lymph node cancers. Also today, four syndromes suggest life-threatening PVL-positive Staphylococcus aureus infection, asthma medication ratio identifies high-risk pediatric patients, and new MS criteria may create more false positives.
For the best experience, listen in Metacast app for iOS or Android
Open in Metacast